Citation: Xiying Wu, Anze Liu, Yuzhong Yan, Ying Lu, Huan Wang. Folic acid ameliorates the immunogenicity of PEGylated liposomes[J]. Chinese Chemical Letters, ;2025, 36(6): 110285. doi: 10.1016/j.cclet.2024.110285 shu

Folic acid ameliorates the immunogenicity of PEGylated liposomes

Xiying Wu ^a ,
Anze Liu ^b ,
Yuzhong Yan ^{c, *} ,
Ying Lu ^{b, *} ,
Huan Wang ^{b, *}

a.
Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200433, China
b.
Department of Pharmaceutical Sciences, School of Pharmacy, Naval Medical University, Shanghai 200433, China
c.
Department of Research and Discipline Development, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China

zp_yanyz@sumhs.edu.cn

acuace@163.com

wang568855641@163.com

Received Date: 29 May 2024
Revised Date: 12 July 2024
Accepted Date: 18 July 2024
Available Online: 19 July 2024

Figures(4)

As PEGylated liposomes have witnessed remarkable advancements in drug delivery, their immunogenicity has emerged as a notable challenge. In this study, we discovered that a simple pre-injection of folic acid (FA) effectively mitigated the immunogenicity of PEGylated liposomes and enhanced their in vivo performance by tolerating splenic marginal zone B cells. FA specifically inhibited the internalization of PEGylated liposomes by splenic marginal zone B cells, thereby reducing splenic lymphocyte proliferation and specific IgM secretion. This modulation alleviated IgM-mediated accelerated blood clearance and adverse accumulation of the PEGylated liposomes in the skin. These findings provide new insights into the immunomodulatory effects of FA and promising avenues to enhance the efficacy and safety of PEGylated liposomal nanomedicines.
- Folic acid,
- Pegylated liposomes,
- Immunogenicity,
- Marginal zone B cells,
- Accelerated blood clearance
1. [1]
  X. Li, J. Gu, Q. Xiao, et al., Chin. Chem. Lett. 34 (2023) 107483. doi: 10.1016/j.cclet.2022.04.081
2. [2]
  M.J. Mitchell, M.M. Billingsley, R.M. Haley, et al., Nat. Rev. Drug Discov. 20 (2021) 101–124. doi: 10.1038/s41573-020-0090-8
3. [3]
  M. Fu, X. Han, B. Chen, et al., Acta Mater. Med. 1 (2022) 486–506.
4. [4]
  K. Elumalai, S. Srinivasan, A. Shanmugam, Biomed. Tech. 5 (2024) 109–122. doi: 10.1016/j.bmt.2023.09.001
5. [5]
  L.J. Kubiatowicz, A. Mohapatra, N. Krishnan, R.H. Fang, L. Zhang, Exploration 2 (2022) 20210217. doi: 10.1002/EXP.20210217
6. [6]
  Y. Li, S. Jacques, H. Gaikwad, et al., Nat. Nanotechnol. 19 (2024) 246–254. doi: 10.1038/s41565-023-01514-z
7. [7]
  M. Ibrahim, E. Ramadan, N.E. Elsadek, et al., J. Control. Release 351 (2022) 215–230. doi: 10.1016/j.jconrel.2022.09.031
8. [8]
  Y.C. Barenholz, J. Control. Release 160 (2012) 117–134. doi: 10.1016/j.jconrel.2012.03.020
9. [9]
  M. Hu, X. Li, Z. You, R. Cai, C. Chen, Adv. Mater. 36 (2023) e2303266.
10. [10]
  X. Wang, H. Wang, K. Jiang, et al., J. Control. Release 293 (2019) 201–214. doi: 10.1016/j.jconrel.2018.12.003
11. [11]
  Y. Bavli, B. Chen, G. Gross, et al., J. Control. Release 354 (2023) 316–322. doi: 10.1016/j.jconrel.2022.12.039
12. [12]
  G. Miao, Y. He, K. Lai, et al., J. Control. Release 363 (2023) 12–26. doi: 10.1016/j.jconrel.2023.09.003
13. [13]
  G.T. Kozma, T. Shimizu, T. Ishida, J. Szebeni, Adv. Drug Deliv. Rev. 154-155 (2020) 163–175. doi: 10.1016/j.addr.2020.07.024
14. [14]
  F. Martin, J.F. Kearney, Nat. Rev. Immunol. 2 (2002) 323–335. doi: 10.1038/nri799
15. [15]
  A. Cerutti, M. Cols, I. Puga, Nat. Rev. Immunol. 13 (2013) 118–132. doi: 10.1038/nri3383
16. [16]
  P. Schriek, A.C. Ching, N.S. Moily, et al., Science 375 (2022) eabf7470. doi: 10.1126/science.abf7470
17. [17]
  M.D. Mcsweeney, L. Shen, A.C. Dewalle, et al., J. Control. Release 329 (2021) 774–781. doi: 10.1016/j.jconrel.2020.10.011
18. [18]
  H. Wang, S. Lin, X. Wu, et al., Adv. Sci. 10 (2023) e2301777. doi: 10.1002/advs.202301777
19. [19]
  L. Shen, Z. Li, A. Ma, et al., ACS Nano 18 (2024) 8733–8744. doi: 10.1021/acsnano.3c11165
20. [20]
  H. Wang, Z. Jiang, Z. Guo, et al., Acta Pharm. Sin. B 14 (2024) 808–820. doi: 10.1016/j.apsb.2023.09.011
21. [21]
  H. Wang, T. Ding, J. Guan, et al., ACS Nano 14 (2020) 14779–14789. doi: 10.1021/acsnano.0c02821
22. [22]
  H. Wang, S. Lin, S. Wang, et al., Nano Lett. 22 (2022) 6516–6522. doi: 10.1021/acs.nanolett.2c01509
23. [23]
  T. Ding, J. Guan, M. Wang, et al., J. Control. Release 319 (2020) 371–381. doi: 10.1016/j.jconrel.2020.01.018
24. [24]
  J. Fu, E. Wu, G. Li, B. Wang, C. Zhan, Nano Today 55 (2024) 102163. doi: 10.1016/j.nantod.2024.102163
25. [25]
  Y. Li, L. Lofchy, G. Wang, et al., ACS Nano 16 (2022) 6349–6358. doi: 10.1021/acsnano.2c00423
26. [26]
  J.I. Griffin, G. Wang, W.J. Smith, et al., ACS Nano 11 (2017) 11584–11593. doi: 10.1021/acsnano.7b06524
1. [1]
  Qiuyu Ming , Huijun Jiang , Zhihao Zhang . A Sightseeing Tour of Folic Acid Processing Plant. University Chemistry, 2024, 39(9): 11-15. doi: 10.12461/PKU.DXHX202404092
2. [2]
  Zhifeng CAI , Ying WU , Yanan LI , Guiyu MENG , Tianyu MIAO , Yihao ZHANG . Effective detection of malachite green by folic acid stabilized silver nanoclusters. Chinese Journal of Inorganic Chemistry, 2025, 41(5): 983-993. doi: 10.11862/CJIC.20240394
3. [3]
  Keqiang Shi , Xiujuan Hong , Dongyan Xu , Tao Pan , Huiwen Wang , Hongru Feng , Cheng Guo , Yuanjiang Pan . Analysis of RNA modifications in peripheral white blood cells from breast cancer patients by mass spectrometry. Chinese Chemical Letters, 2025, 36(3): 110079-. doi: 10.1016/j.cclet.2024.110079
4. [4]
  Wenyi Mei , Lijuan Xie , Xiaodong Zhang , Cunjian Shi , Fengzhi Wang , Qiqi Fu , Zhenjiang Zhao , Honglin Li , Yufang Xu , Zhuo Chen . Design, synthesis and biological evaluation of fluorescent derivatives of ursolic acid in living cells. Chinese Chemical Letters, 2024, 35(5): 108825-. doi: 10.1016/j.cclet.2023.108825
5. [5]
  Zhen Liu , Zhi-Yuan Ren , Chen Yang , Xiangyi Shao , Li Chen , Xin Li . Asymmetric alkenylation reaction of benzoxazinones with diarylethylenes catalyzed by B(C₆F₅)₃/chiral phosphoric acid. Chinese Chemical Letters, 2024, 35(5): 108939-. doi: 10.1016/j.cclet.2023.108939
6. [6]
  Luyan Shi , Ke Zhu , Yuting Yang , Qinrui Liang , Qimin Peng , Shuqing Zhou , Tayirjan Taylor Isimjan , Xiulin Yang . Phytic acid-derivative Co₂B-CoPO_x coralloidal structure with delicate boron vacancy for enhanced hydrogen generation from sodium borohydride. Chinese Chemical Letters, 2024, 35(4): 109222-. doi: 10.1016/j.cclet.2023.109222
7. [7]
  Peide Zhu , Yangjia Liu , Yaoyao Tang , Siqi Zhu , Xinyang Liu , Lei Yin , Quan Liu , Zhiqiang Yu , Quan Xu , Dixian Luo , Juncheng Wang . Bi-doped carbon quantum dots functionalized liposomes with fluorescence visualization imaging for tumor diagnosis and treatment. Chinese Chemical Letters, 2024, 35(4): 108689-. doi: 10.1016/j.cclet.2023.108689
8. [8]
  Li Li , Jiale Wen , Xiaojun Zhang , Shuwen Fu , Zixuan Chen , Kai Huang , Luyue Fang , Tinghe Zhao , Peipei Zhang , Xingshu Li . A near-infrared naphthalocyanine photosensitizer with superior light absorption and renal clearance for type-Ⅰ photodynamic and photothermal combination therapy. Chinese Chemical Letters, 2025, 36(6): 110290-. doi: 10.1016/j.cclet.2024.110290
9. [9]
  Han Wu , Yumei Wang , Zekai Ren , Hailin Cong , Youqing Shen , Bing Yu . The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy. Chinese Chemical Letters, 2025, 36(4): 109996-. doi: 10.1016/j.cclet.2024.109996
10. [10]
  Fereshte Hassanzadeh-Afruzi , Mina Azizi , Iman Zare , Ehsan Nazarzadeh Zare , Anwarul Hasan , Siavash Iravani , Pooyan Makvandi , Yi Xu . Advanced metal-organic frameworks-polymer platforms for accelerated dermal wound healing. Chinese Chemical Letters, 2024, 35(11): 109564-. doi: 10.1016/j.cclet.2024.109564
11. [11]
  Shudi Yu , Jie Li , Jiongting Yin , Wanyu Liang , Yangping Zhang , Tianpeng Liu , Mengyun Hu , Yong Wang , Zhengying Wu , Yuefan Zhang , Yukou Du . Built-in electric field and core-shell structure of the reconstructed sulfide heterojunction accelerated water splitting. Chinese Chemical Letters, 2024, 35(12): 110068-. doi: 10.1016/j.cclet.2024.110068
12. [12]
  Jing Guo , Zhi-Guo Lu , Rui-Chen Zhao , Bao-Ku Li , Xin Zhang . Nucleic acid therapy for metabolic-related diseases. Chinese Chemical Letters, 2025, 36(3): 109875-. doi: 10.1016/j.cclet.2024.109875
13. [13]
  Shushan Mo , Zhaoshuo Wang , Dandan Ding , Zhengzheng Yan , Yunlu Dai , Jinchao Zhang , Huifang Liu , Tianjiao Liang , Jianfei Tong , Zhenhua Li , Xueyi Wang . The synthesis and evaluation of novel BPA derivatives for enhanced blood-brain barrier penetration and boron neutron capture therapy. Chinese Chemical Letters, 2025, 36(5): 110190-. doi: 10.1016/j.cclet.2024.110190
14. [14]
  Tengfei Xuan , Xinyu Zhang , Wei Han , Yidong Huang , Weiwu Ren . Total synthesis of (+)-taberdicatine B and (+)-tabernabovine B. Chinese Chemical Letters, 2025, 36(2): 109816-. doi: 10.1016/j.cclet.2024.109816
15. [15]
  Jisheng Liu , Junli Chen , Xifeng Zhang , Yin Wu , Xin Qi , Jie Wang , Xiang Gao . Red blood cell membrane-coated FLT3 inhibitor nanoparticles to enhance FLT3-ITD acute myeloid leukemia treatment. Chinese Chemical Letters, 2024, 35(9): 109779-. doi: 10.1016/j.cclet.2024.109779
16. [16]
  Lei Shen , Hongmei Liu , Ming Jin , Jinchao Zhang , Caixia Yin , Shuxiang Wang , Yutao Yang . “Three-in-one” strategy of trifluoromethyl regulated blood-brain barrier permeable fluorescent probe for peroxynitrite and antiepileptic evaluation of edaravone. Chinese Chemical Letters, 2024, 35(10): 109572-. doi: 10.1016/j.cclet.2024.109572
17. [17]
  Huipeng Zhao , Xiaoqiang Du . Polyoxometalates as the redox anolyte for efficient conversion of biomass to formic acid. Chinese Journal of Structural Chemistry, 2024, 43(2): 100246-100246. doi: 10.1016/j.cjsc.2024.100246
18. [18]
  Dan-Ying Xing , Xiao-Dan Zhao , Chuan-Shu He , Bo Lai . Kinetic study and DFT calculation on the tetracycline abatement by peracetic acid. Chinese Chemical Letters, 2024, 35(9): 109436-. doi: 10.1016/j.cclet.2023.109436
19. [19]
  Lihang Wang , Mary Li Javier , Chunshan Luo , Tingsheng Lu , Shudan Yao , Bing Qiu , Yun Wang , Yunfeng Lin . Research advances of tetrahedral framework nucleic acid-based systems in biomedicine. Chinese Chemical Letters, 2024, 35(11): 109591-. doi: 10.1016/j.cclet.2024.109591
20. [20]
  Li Fu , Ziye Su , Shuyang Wu , Yanfen Cheng , Chuan Hu , Jinming Zhang . Redox-responsive hyaluronic acid-celastrol prodrug micelles with glycyrrhetinic acid co-delivery for tumor combination therapy. Chinese Chemical Letters, 2025, 36(5): 110227-. doi: 10.1016/j.cclet.2024.110227

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(150)
HTML views(3)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142